Achilles Therapeutics plc (ACHL)

Mar 20, 2025 - ACHL was delisted pending liquidation

1.480

0.00 (0.00%)

Inactive · Last trade price on Mar 21, 2025

Achilles Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-66.88	-69.67	-71.18	-61.1	-33.2	-13.99
Depreciation & Amortization	4.7	4.71	3.69	3.29	0.77	0.3
Loss (Gain) From Sale of Assets	0.31	0	-0.01	0.16	-	0.01
Asset Writedown & Restructuring Costs	0.49	0.02	7.45	-	-	-
Stock-Based Compensation	5.27	6.36	7.02	6.32	2.99	0.72
Other Operating Activities	-0.16	-0.28	-0.55	-0.02	1.18	-0.01
Change in Accounts Payable	-1.38	0.26	1.91	-2.57	5.26	0.55
Change in Income Taxes	-	-0.33	0.33	-0.01	0.01	-
Change in Other Net Operating Assets	-5.76	10.27	-7.96	-5.33	-2.26	-1.73
Operating Cash Flow	-63.26	-48.45	-59.54	-59.28	-25.25	-14.14
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Capital Expenditures	-0.81	-1.1	-7.51	-7.63	-11.85	-0.94
Investing Cash Flow	-0.81	-1.1	-7.51	-7.63	-11.85	-0.94

Financing Activities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Issuance of Common Stock	0.01	0.01	0	160.76	-	-
Other Financing Activities	-	-	-	-	-0.12	-
Financing Cash Flow	0.01	0.01	0	160.76	113.7	93.62

Net Cash Flow

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Foreign Exchange Rate Adjustments	9.96	7.74	-25.94	-5.33	3.65	8.37
Net Cash Flow	-54.1	-41.8	-92.98	88.5	80.26	86.91

Free Cash Flow

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Free Cash Flow	-64.07	-49.55	-67.05	-66.92	-37.1	-15.08
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-1.59	-1.24	-1.71	-2.33	-34.80	-23.49
Levered Free Cash Flow	-44.71	-28.2	-46.92	-44.85	-24.37	-8.96
Unlevered Free Cash Flow	-44.71	-28.2	-46.92	-44.85	-24.37	-8.96

SEC Filings: 10-K · 10-Q